Breaking News
April 19, 2018 - Environmental pollutants found to worsen rheumatoid arthritis
April 19, 2018 - UT Southwestern scientists discover protein linked to metastatic breast cancer
April 19, 2018 - Study highlights need for further evidence to improve symptom management in end of life care
April 19, 2018 - Detecting diminished dopamine-firing cells inside brain could reveal earliest signs of Alzheimer’s
April 19, 2018 - Case study shows how intravascular ultrasound imaging helps detect acute aortic syndrome
April 19, 2018 - Research reveals new mechanism by which HIV evades the immune system
April 19, 2018 - Nanodisc-delivered cancer treatment helps eliminate tumors
April 19, 2018 - Functional connectivity MRI could help detect brain disorders and diseases
April 19, 2018 - Finding better way to quantify neuropathy symptoms and treatment efficacy
April 19, 2018 - Study examines effectiveness of caregiver education about sickle cell trait
April 19, 2018 - High-resolution images of tumor vasculature using new technology
April 19, 2018 - Lack of sleep may be linked to risk factor for Alzheimer’s disease
April 19, 2018 - Study finds neurotransmitter may play a role in alcohol relapse, addiction
April 19, 2018 - Researchers build molecular networks of calcific aortic valve disease
April 19, 2018 - Researchers develop highly specific apoptosis assay for pharmacodynamic analyses of tumor specimens
April 19, 2018 - Scientists decipher mechanism of chemotherapy induced female infertility
April 19, 2018 - New insight may allow researchers to design drugs that improve immune responses to vaccines
April 19, 2018 - FDA Approves Crysvita (burosumab-twza) for X-Linked Hypophosphatemia
April 19, 2018 - Researchers uncover origin of virus-fighting plasma B cells
April 19, 2018 - Study finds no evidence of lower intelligence in young children who had anesthesia
April 19, 2018 - Baboons break out of research facility briefly
April 19, 2018 - Study shows how deployment time increases risk of suicide attempt in soldiers
April 19, 2018 - Specific odors from malaria infected individuals attract more mosquitoes
April 19, 2018 - FDA Alert: Rhino 69 Extreme 50000 by AMA Wholesale: Recall
April 19, 2018 - Top HIV cure research team refutes major recent results on how to identify HIV persistence
April 19, 2018 - Experts propose new solutions to increase benefit, affordability of targeted cancer medicines
April 19, 2018 - Deficiency of innate immune adaptor TRIF shortens survival time of ALS mice
April 19, 2018 - New machine learning method offers better way to detect heart disease
April 19, 2018 - CNIO researchers determine structure of protein complex related to cell survival
April 19, 2018 - Faith-based diabetes support program launched by UTSA research team
April 19, 2018 - Volumetric Laser Endomicroscopy Helps ID Barrett’s Regions
April 19, 2018 - Engineered cartilage template to heal broken bones
April 19, 2018 - New computational framework accurately predicts drug-drug and drug-food interactions
April 18, 2018 - Some human cancers may be result of evolutionary accidents, research finds
April 18, 2018 - Higher levels of education linked to lower dementia risk in older African Americans
April 18, 2018 - Smoking Puts Blacks at Higher Risk for Heart Failure
April 18, 2018 - Physiotherapist contributes to guidelines for knee cartilage treatment
April 18, 2018 - Researchers use ‘top-down proteomics’ strategy to get new insights into cancer
April 18, 2018 - Physician assistants less likely to accurately diagnose early stage skin cancers
April 18, 2018 - New faster, streamlined method for bowel cancer detection and treatment
April 18, 2018 - Researchers identify new Listeria species in Costa Rica
April 18, 2018 - Novel interactive diagram shows many facets of mild traumatic brain injury
April 18, 2018 - Short sleep linked to obesity in children and adolescents
April 18, 2018 - When weight loss helps with sleep
April 18, 2018 - New mathematical model can predict efficiency of microbiome therapies
April 18, 2018 - People with high LDL cholesterol levels likely to get greater benefits from statins
April 18, 2018 - Listening to music enhances effect of anti-hypertensive drugs
April 18, 2018 - New method could help treat severe epilepsy in the future
April 18, 2018 - Study reveals increased risks for Alzheimer’s, suicide among youth in polluted cities
April 18, 2018 - Obese patients more likely to develop rapid and irregular heart rate
April 18, 2018 - Study may change global guidelines for managing children with uncomplicated fever
April 18, 2018 - Researchers find letter we’ve seen millions of times, yet can’t write
April 18, 2018 - Roswell Park researchers identify driver of cancer-promoting metabolic changes
April 18, 2018 - Study shows connection between early life stress, depression and sleep disturbances
April 18, 2018 - New tool developed to protect women from HIV infection
April 18, 2018 - Tradeshow Talks with HealthSapiens
April 18, 2018 - NYC mice carry deadly bacteria and viruses
April 18, 2018 - FDA Approves Tavalisse (fostamatinib disodium hexahydrate) for Chronic Immune Thrombocytopenia
April 18, 2018 - Doctors curbing first-time prescriptions for opioids
April 18, 2018 - Scientists analyze nanostructure of chicken eggshells
April 18, 2018 - Study finds muscle complications among active young adults with Type 1 diabetes
April 18, 2018 - Young children should be priority for snail fever treatment
April 18, 2018 - One class of diabetes drug not associated with reduced risk of death
April 18, 2018 - Breakthrough microscope revolutionizes live cell imaging of stem cells
April 18, 2018 - Study on arthritis prevalence and trends reveals unexpected findings
April 18, 2018 - Low-Vision Rehab Improves Several Elements of Visual Function
April 18, 2018 - Babies who look like their father at birth are healthier one year later: study
April 18, 2018 - New drug for migraine in the pipeline
April 18, 2018 - Precancerous colon polyps in Lynch syndrome patients display immune activation
April 18, 2018 - Mouse study shows how tungsten accumulates in the bones
April 18, 2018 - Scientists provide insight into how gene associated with autoimmunity contributes to disease
April 18, 2018 - AHA: Rx for Sedentary Kids — Friends and the Great Outdoors
April 18, 2018 - Expert panel reliable and accurate in identifying injuries in young children
April 18, 2018 - Two immune checkpoint inhibitors efficiently block leukemia development in preclinical tests
April 18, 2018 - New automated text messaging service may help combat opioid epidemic
April 18, 2018 - Large ALS-causing protein aggregates protect rather than harm neurons
April 18, 2018 - Older adults in high-quality nursing homes have lower risks for placement in long-term care facilities
April 18, 2018 - Targeting opioid receptor offers relief for chronic itching
April 18, 2018 - PBO long-lasting insecticidal nets found to be effective in reducing malaria prevalence
April 18, 2018 - New study maps links between 625 genes and different chemotherapy treatments
Inhaled Nitrite Flops as HFpEF Therapy

Inhaled Nitrite Flops as HFpEF Therapy

image_pdfDownload PDFimage_print

ORLANDO — An inhaled inorganic nitrite improved neither exercise capacity nor general clinical status for patients with heart failure with preserved ejection fraction (HFpEF), according to the INDIE-HFpEF trial.

Delivery of the compound by nebulizer did not improve peak exercise capacity on cardiopulmonary exercise testing, as it left patients with the same 14 ml/min/kg VO2 as their peers randomized to placebo (P=0.27), Barry Borlaug, MD, of the Mayo Clinic in Rochester, Minnesota, reported at the annual American College of Cardiology meeting here.

The nitrite did not increase daily activity or patient-reported quality of life. It also failed to improve heart failure symptom severity and cardiac congestion. But nor was there an uptick in severe adverse events with the inhaled compound, the presenter said during the late-breaking trial session.

“These data do not support use of inhaled, nebulized inorganic nitrite for symptom relief in patients with HFpEF,” he concluded. The hope was that inorganic nitrite, which restores nitric oxide, might improve exercise capacity and clinical status in patients with HFpEF given evidence suggesting that impaired nitric oxide signalling may drive heart failure.

“HFpEF remains an enormous unmet public health problem. Further study is required to determine the potential efficacy of other nitric oxide-providing therapies in HFpEF,” Borlaug urged.

Previously, researchers had found that organic nitrate supplementation was poorly tolerated and in fact reduced patient activity levels.

Session panelist Lee Goldberg, MD, MPH, of the Hospital of the University of Pennsylvania in Philadelphia, said he was left wondering after the INDIE-HFpEF presentation if the inhaled nitrite was actually being absorbed and whether researchers have been targeting the wrong pathway in HFpEF all along.

The trial “certainly doesn’t support the hypothesis” that it’s nitric oxide that’s driving HFpEF, the presenter responded. Yet there are several ways to target it upstream or downstream, he said, making him unwilling to discard therapies aimed at nitric oxide just yet.

Click here for video comments from study authors and discussants at ACC 2018.

After all, it is possible that the inorganic nitrite could have worked with a longer duration of exposure or perhaps in combination with exercise training, Borlaug said. Oral nitrate is another alternative, as it is converted by bacteria in the mouth to nitrite, that is now being tested in other studies, according to the investigator.

For the INDIE-HFpEF trial, researchers across 20 centers participating in the NHLBI Heart Failure Clinical Research Network randomized 105 participants in their double-blind crossover study. Patients started with 4 weeks on inhaled nitrite or placebo (three times a day) before a switch to 4 weeks on placebo or vice versa.

Heart failure patients were included if they had reduced exercise capacity with New York Heart Association class II-IV symptoms and an ejection fraction of at least 50%. The nitrite-first group had more women and more patients with diabetes.

“That there is an unmet need for a therapy to improve the outcomes of these patients is an understatement,” commented James Januzzi, MD, of Massachusetts General Hospital in Boston, at a press conference. “When we say we have few therapies … we mean we have no therapies to improve outcomes in these patients.”

Januzzi said the study was “exceptionally important” while arguing that it doesn’t close the door on nitric oxide therapy given its “very strong scientific basis.”

“There’s still a lot of work to do in this space and the study does point in a direction for us. Someone is going to figure it out sooner or later,” he predicted.

Borlaug disclosed receiving consultant fees or honoraria from Actelion, Amgen, Arteriomedix, Merck, and MyoKardia; and research grants from AstraZeneca, Corvia, GlaxoSmithKline, Medtronic, and Mesoblast.

Goldberg declared consultant fees, honoraria, or both from Medtronic and research grants from Respircardia.

Januzzi reported consultant fees and/or honoraria from Abbott Laboratories, Critical Diagnostics, Phillips, and Roche Diagnostics; serving on Data Safety Monitoring Boards for AbbVie, Amgen, Boeringer Ingelheim, Janssen, and Siemens; and receipt of research grants from Cleveland Heart Labs, Novartis, Prevencio, and Singulex.

2018-12-03T00:00:00-0500

last updated

Tagged with:

About author

Related Articles